DGAP-News

Geratherm Medical AG: The international medical journal ´Stroke´ published convincing results of a clinical trial conducted at the University Hospital Heidelberg, Germany

DGAP-News: Geratherm Medical AG / Key word(s): Study
Geratherm Medical AG: The international medical journal ´Stroke´
published convincing results of a clinical trial conducted at the
University Hospital Heidelberg, Germany

08.08.2012 / 10:11

---

Clinical Trial Substantiates Superiority of SRAclinic in the Detection of
Atrial fibrillation

The international medical journal ´Stroke´  published  convincing results
of a clinical trial conducted at the University Hospital Heidelberg,
Germany

SRAclinic shows significant superiority over standard procedures - 40
percent more patients with paroxysmal atrial fibrillation identified

Geratherm/apoplex, Pirmasens, 08. August  2012. Throughout Germany, in
France and Austria, more than 30 hospitals (stroke units) already use
successfully the fully automated ECG analysis for the detection of atrial
fibrillation SRAclinic (SRA = Stroke Risk Analysis), developed by the
apoplex medical technologies GmbH, Pirmasens (Germany). The medical journal
´Stroke´, an official journal of the American Heart Association, just
published the results of a clinical trial, which proves a clear superiority
of SRAclinic* to the current standard procedures for the detection of
paroxysmal atrial fibrillation. This is of great importance especially for
those patients with strokes of unknown origin. Only the detection of atrial
fibrillation makes an adequate therapy with anticoagulating drugs possible
to reduce the risk for further strokes.

The publication in ´Stroke´ is based on a prospective study conducted by
the principal investigator Prof. Dr. med. Roland Veltkamp, between March
2010 and January 2011 on approximately 500 patients at the stroke unit of
the University Hospital Heidelberg. The study compared the detection rate
of paroxysmal atrial fibrillation of SRAclinic with the current standard
procedure. The investigators succeeded in proofing superiority of SRAclinic
over the 24 hour long term ECG and the ECG monitoring without the automated
detection software in the identification of patients with paroxysmal atrial
fibrillation.

´SRAclinic has clearly proven it´s superiority over the elaborate methods
used in our stroke unit to detect atrial fibrillation´, states Prof. Dr.
med. Roland Veltkamp. ´After the analysis of the study results we changed
the routine diagnostic for the detection of paroxysmal atrial fibrillation
at our stroke unit with 20 beds completely to SRAclinic. The anyway
recorded ECG signals from the monitoring system at the stroke unit are
analysed by SRAclinic. 24 hour long term ECGs are only recorded in